AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2008
Feb 5, 2008
30786_dirs_2008-02-05_2b83992a-e730-4f22-b219-0cc5af80f31f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2008-02-05
Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-05 | Bio-Rad B Common Stock | M | 6296 | $39.60 | Acquired | 63834 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-05 | Incentive Stock Option (right to buy) | $39.60 | M | 6296 | Disposed | 2008-02-05 | Bio-Rad B Common Stock (6296) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 211454 | Direct |
| Bio-Rad B Common Stock | 363440 | Indirect |
| Bio-Rad B Common Stock | 13726 | Indirect |
| Bio-Rad B Common Stock | 10960 | Indirect |
Footnotes
F1: The shares are held by a limited partnership of which the reporting person is a general partner.
F2: The shares are held by a limited partnership of which the reporting person is a limited partner.
F3: The reporting person disclaims beneficial ownership of these shares.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13